FR2927256B1 - Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation - Google Patents

Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation

Info

Publication number
FR2927256B1
FR2927256B1 FR0800762A FR0800762A FR2927256B1 FR 2927256 B1 FR2927256 B1 FR 2927256B1 FR 0800762 A FR0800762 A FR 0800762A FR 0800762 A FR0800762 A FR 0800762A FR 2927256 B1 FR2927256 B1 FR 2927256B1
Authority
FR
France
Prior art keywords
alfa
amylase
preparing
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0800762A
Other languages
English (en)
Other versions
FR2927256A1 (fr
Inventor
Jean Chatillon
Paul Ghislain Coupan
Murielle Trinquier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Top Pharm SARL
Original Assignee
Laboratoire Top Pharm SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Top Pharm SARL filed Critical Laboratoire Top Pharm SARL
Priority to FR0800762A priority Critical patent/FR2927256B1/fr
Publication of FR2927256A1 publication Critical patent/FR2927256A1/fr
Application granted granted Critical
Publication of FR2927256B1 publication Critical patent/FR2927256B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
FR0800762A 2008-02-13 2008-02-13 Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation Expired - Fee Related FR2927256B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0800762A FR2927256B1 (fr) 2008-02-13 2008-02-13 Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0800762A FR2927256B1 (fr) 2008-02-13 2008-02-13 Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation

Publications (2)

Publication Number Publication Date
FR2927256A1 FR2927256A1 (fr) 2009-08-14
FR2927256B1 true FR2927256B1 (fr) 2010-05-14

Family

ID=39790816

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0800762A Expired - Fee Related FR2927256B1 (fr) 2008-02-13 2008-02-13 Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation

Country Status (1)

Country Link
FR (1) FR2927256B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2972639B1 (fr) * 2011-03-18 2013-11-08 Top Pharm Lab Composition pharmaceutique anti-inflammatoire

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
JP2000247873A (ja) * 1999-02-24 2000-09-12 Taisho Pharmaceut Co Ltd 粘膜部位の違和感解消用組成物
FR2800614B1 (fr) * 1999-11-10 2002-01-04 Top Pharm Lab Composition pour le traitement des infections des voies respiratoires
FR2827776B1 (fr) * 2001-07-25 2005-09-30 Top Pharm Lab Composition comprenant un anti-inflammatoire enzymatique et un mucolytique

Also Published As

Publication number Publication date
FR2927256A1 (fr) 2009-08-14

Similar Documents

Publication Publication Date Title
FR22C1062I2 (fr) Thérapie de remplacement enzymatique d'escalade de doses pour le traitement du déficit en sphingomyélinase acide
EP2151435A4 (fr) Composition pharmaceutique pour le traitement de la maladie d'alzheimer
LTC2787345I2 (lt) Fabri ligos gydymo priemonės
ME02414B (fr) Traitement de la maladie de crohn au moyen de laquinimod
JP2015501783A5 (fr)
IL208926A0 (en) Use of epothelone d in treating tau-associated diseases including alzheimer's disease
ZA201100034B (en) Pharmaceutical compositions for treatment of parkinson's disease
PL2104682T3 (pl) Diagnostyka i leczenie choroby Alzheimera i innych chorób neurodegeneracyjnych
IL217901B (en) Use of laquinimod or a laquinimod salt in the manufacture of a drug for the treatment of bdnf-related diseases
MX2012004525A (es) Compuestos.
MY152279A (en) Immediate release pharmaceutical compositions comprising oxycodone and naloxone
IL201189A (en) Fluorization derivatifrone derivatives used as iron pellets in the treatment of neurodegenerative diseases, their preparation and their pharmaceutical preparations
EP2268647A4 (fr) Composés et compositions pour la détection et le traitement de la maladie d'alzheimer et des troubles associés
HK1176548A1 (en) Pharmaceutical for oral delivery comprising mgbg and methods of treating disease mgbg
EP2306824A4 (fr) Administration par ionophorèse de curcumine et analogues de curcumine destinés au traitement de la maladie d'alzheimer
MA38169A1 (fr) Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux
FR2918282B1 (fr) Medicament pour le traitement de la maladie de parkinson
IL218001A (en) Pharmaceuticals for the treatment of inflammatory diseases mediated 1 mcp
EP2391379A4 (fr) Composé et procédé de traitement de la maladie d'alzheimer
FR2927256B1 (fr) Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation
FR2947729B1 (fr) Composition pharmaceutique pour le traitement du diabete de type ii par voie trans-muqueuse buccale
FR2910324B1 (fr) Nouveau medicament pour le traitement d'un cancer gastrique
FR2924593B1 (fr) Plaque osseuse pour le traitement de l'extremite inferieure du cubitus
FR2931075B1 (fr) Extrait de fenugrec pour le traitement des pathologies humaines et animales impliquant des parasites flagelles
FR2954699B1 (fr) Composition pharmaceutique pour le traitement de la dependance a l'alcool

Legal Events

Date Code Title Description
CD Change of name or company name

Owner name: LABORATOIRE TOP-PHARMA, FR

Effective date: 20120118

TP Transmission of property

Owner name: LABORATOIRE TOP-PHARMA, FR

Effective date: 20120118

ST Notification of lapse

Effective date: 20131031